Since GSDME ectopic expression caused increased tumoral T-cell infiltration (Fig. S2m) and ICB functions by recovering or enhancing the effector activity of CD8+ T cells, we speculated that ICB therapy might synergize with TKI therapy, particularly in GSDME-expressing HCC. This evidence concerns the gene CD8A and hepatocellular carcinoma.